Clinical Trials

Pilot Study of NovoTTF in Conjunction with Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma


Study ID
HUMC IST NovoChemoRads

NCT Number
NCT03232424 (Click on the NCT number for more information about the trial)

Research Study Number
2017-0087

Principle Investigator
Dr. Samuel Goldlust

Phase
I

Sponsor
HackensackUMC


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now